Amylyx Pharmaceuticals, Inc. Common Stock AMLX
$29.49
-2.16%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 4 | 4 | 2026-09-14 | View → |
| 8-K | 8-K | 2026-09-08 | View → |
| 4 | 4 | 2026-09-02 | View → |
| 4 | 4 | 2026-08-20 | View → |
| 4 | 4 | 2026-08-20 | View → |
| 4 | 4 | 2026-08-20 | View → |
| 4 | 4 | 2026-08-20 | View → |
| 4 | 4 | 2026-08-20 | View → |
| 8-K | 8-K | 2026-08-20 | View → |
| 424B5 | 424B5 | 2026-08-20 | View → |
| 424B5 | 424B5 | 2026-08-18 | View → |
| 8-K | 8-K | 2026-08-18 | View → |
| 8-K | 8-K | 2026-08-18 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | 4 | 2026-07-13 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 4 | 4 | 2026-06-08 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | 4 | 2026-05-26 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| DEF 14A | DEF 14A | 2026-04-23 | View → |
| 8-K | 8-K | 2026-03-24 | View → |
| 4 | 4 | 2026-03-09 | View → |
| 4 | 4 | 2026-03-09 | View → |
| 4 | 4 | 2026-03-09 | View → |
| 4 | 4 | 2026-03-09 | View → |
| 4 | 4 | 2026-03-09 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $29.49
- Market Cap
- $3.76 billion
- 52-Week Range
- $8.47 – $41.14
- Average Volume
- 3.03 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.